课题基金 / 基金详情

Developing cancer therapies through targeting the Six1/Eya transcriptional complex

Developing cancer therapies through targeting the Six1/Eya transcriptional complex
通过靶向 Six1/Eya 转录复合物开发癌症疗法
批准号:
8989081
负责人:
Heide L. Ford
金额:
$20.29万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-12-18 至 2016-11-30

项目摘要

项目成果

Heide L. Ford的其他基金

相似基金

相关文献

中文摘要
翻译

英文摘要
 DESCRIPTION (provided by applicant): Most anti-cancer drugs target binding pockets in enzymes or on protein receptors. These drugs often target upstream pathways that can cripple tumors, but may fail to hit the central node of the tumor. For some time, it has been known that transcription factors can serve as these "central nodes". Indeed, de-regulated transcription has been associated with most, if not all, properties that are critical to the cancer cell, including uncontrolled growth, unlimited replicative potential, migration and invasion. Yet few investigators have taken on the more difficult task of targeting transcription factors. The Six1 homeobox gene encodes a transcription factor that is critical for embryonic development. In most tissues, Six1 expression is lost once development is complete. However, Six1 is re-activated in as many as 50% of primary breast tumors and 90% of metastatic lesions, as well as in many other tumor types. Six1 plays a causal role in tumor initiation, tumor growth, and metastasis of breast and other cancers, and its inhibition dramatically diminishes the aforementioned properties in several mouse models of cancer. Six1 has no intrinsic activation or repression domains, and thus requires cofactors to mediate its transcriptional effects. We have demonstrated that Six1 requires the Eya cofactor to mediate its pro-proliferative and pro-metastatic effects in breast cancer cells. Examination of public breast cancer microarray datasets reveals that high expression levels of Six1 and Eya together, but not either gene alone, correlate with shortened time to relapse, shortened time to metastasis, and shortened overall survival in breast cancer. Importantly, we recently determined the crystal structure of the Six1/Eya2 complex, which reveals that Six1 uses a single alpha helix to interact with Eya, resembling two well-known protein- protein interactions (p53/HDM2 and Bak/Bcl-xL) that have been successfully targeted by small molecules. We further demonstrated that a single amino acid mutation on the Six1 helix abrogates the binding of Six1 to Eya and Six1-mediated tumor initiation and metastasis. The goal of this project is to identify and develop novel anti- cancer agents that target the Six1/Eya complex through characterizing and optimizing hit compounds identified through the use of a high throughput screen (Aim 1). Identified inhibitors will be tested in both cell culture and animal models for their ability to inhibit tumorigenicity and metastasis (Aim 2). Since the Six1/Eya complex influences multiple stages of the tumorigenic and metastatic processes and is not expressed in most adult tissues, targeting this never before targeted complex has the therapeutic potential to inhibit breast and other cancers both at early and later stages of disease progression with limited side effects, something most current therapies do not do.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1535-7163.mct-16-0592
发表时间: 2017-06
期刊: Molecular cancer therapeutics
影响因子: 5.7
作者: [Blevins MA, Huang M, Zhao R]
通讯作者: Zhao R
Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis
  • 批准号:
    9900185
  • 项目类别:
  • 资助金额:
    $3.0万
  • 财政年份:
    2019
  • 负责人:
    Heide L. Ford
  • 依托单位:
Examining the EYA2/MYC axis in Group 3 Medulloblastoma
  • 批准号:
    9753388
  • 项目类别:
  • 资助金额:
    $42.51万
  • 财政年份:
    2018
  • 负责人:
    Heide L. Ford
  • 依托单位:
Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis
  • 批准号:
    10296675
  • 项目类别:
  • 资助金额:
    $60.15万
  • 财政年份:
    2018
  • 负责人:
    Heide L. Ford
  • 依托单位:
Deciphering Mechanisms by which Tumor Cells Collaborate to Mediate Metastasis
  • 批准号:
    10531902
  • 项目类别:
  • 资助金额:
    $60.15万
  • 财政年份:
    2018
  • 负责人:
    Heide L. Ford
  • 依托单位:
海外基金